Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 139th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
MLYS	MINERALYS THERAPEUTICS INC	$13.35	-1.11%	9.52%	-6.12%	44.48%	-3.82%	11.25%	N/A	N/A	N/A	$18.38	$8.24	27.37%	61.99%	1.03	382,306	-20.04%
IBIO	IBIO INC	$0.89	-9.18%	-26.45%	-81.69%	-68.55%	-68.77%	-52.91%	-99.48%	-99.80%	-99.98%	$6.89	$0.87	87.08%	2.18%	1.10	499,746	-23.22%
PRME	PRIME MEDICINE INC	$1.24	0.00%	5.98%	-29.14%	-57.09%	-67.37%	-74.85%	N/A	N/A	N/A	$8.27	$1.12	85.01%	11.21%	1.91	457,965	-43.19%
ANIX	ANIXA BIOSCIENCES INC	$2.72	-1.09%	2.26%	-10.23%	12.86%	-9.03%	-10.82%	5.84%	36.68%	-22.29%	$4.20	$2.07	35.24%	31.40%	0.93	19,009	28.72%
BCAX	BICARA THERAPEUTICS INC	$12.16	3.40%	19.80%	-9.93%	0.41%	-40.51%	N/A	N/A	N/A	N/A	$28.09	$8.91	56.71%	36.48%	1.34	521,081	-19.78%
RZLT	REZOLUTE INC	$2.75	4.17%	11.34%	-21.43%	-43.53%	-41.98%	-15.12%	-24.45%	N/A	N/A	$6.19	$2.22	55.54%	24.15%	0.70	907,230	32.79%
KRON	KRONOS BIO INC	$0.89	0.91%	14.14%	-6.43%	-10.39%	-4.52%	-14.62%	-84.17%	N/A	N/A	$1.60	$0.69	44.50%	28.70%	1.30	11,027	-85.17%
TRVI	TREVI THERAPEUTICS INC	$6.07	-0.49%	14.96%	-7.19%	61.44%	94.55%	135.27%	79.06%	123.16%	N/A	$7.39	$2.30	17.86%	163.91%	0.74	710,037	-7.28%
BIVI	BIOVIE INC	$0.84	6.05%	13.50%	-23.55%	-62.46%	-24.91%	-82.16%	-98.09%	N/A	N/A	$7.50	$0.62	88.79%	35.65%	1.50	54,368	-22.78%
AKRO	AKERO THERAPEUTICS INC	$37.63	0.51%	8.07%	-16.04%	49.68%	22.10%	74.21%	231.25%	83.03%	N/A	$58.40	$17.86	35.57%	110.69%	0.57	521,577	4.71%
ALGS	ALIGOS THERAPEUTICS INC	$4.68	2.41%	17.29%	-59.90%	-86.33%	-35.09%	-76.21%	-87.18%	N/A	N/A	$46.80	$3.76	90.00%	24.47%	1.31	79,751	-19.49%
MBX	MBX BIOSCIENCES INC	$7.62	1.46%	21.53%	-13.90%	-22.95%	-67.10%	N/A	N/A	N/A	N/A	$27.50	$4.81	72.29%	58.52%	1.32	218,710	-30.16%
VERV	VERVE THERAPEUTICS INC	$4.59	1.77%	50.49%	-27.37%	-25.24%	-15.93%	-31.90%	-75.75%	N/A	N/A	$9.31	$2.87	50.67%	60.21%	2.00	2,594,072	-63.29%
INMB	INMUNE BIO INC	$7.32	0.14%	8.77%	-4.56%	13.49%	46.40%	-13.17%	-2.14%	66.74%	N/A	$12.72	$4.32	42.45%	69.44%	1.39	174,672	-24.32%
DSGN	DESIGN THERAPEUTICS INC	$3.50	3.55%	25.45%	-29.01%	-30.83%	-41.86%	-11.17%	-75.18%	N/A	N/A	$7.77	$2.60	54.95%	34.62%	1.42	92,217	-12.26%
MAIA	MAIA BIOTECHNOLOGY INC	$1.55	0.65%	6.16%	-7.19%	-22.50%	-38.37%	-21.72%	N/A	N/A	N/A	$5.99	$1.40	74.12%	10.71%	0.49	36,735	63.53%
NVCT	NUVECTIS PHARMA INC	$8.87	1.90%	3.99%	-6.59%	61.48%	31.14%	31.14%	-7.66%	N/A	N/A	$11.80	$4.44	24.87%	99.66%	0.27	125,600	7.05%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$11.24	-0.97%	1.17%	-27.95%	-42.54%	-46.07%	-50.11%	-74.64%	-69.25%	58.76%	$30.41	$9.57	63.04%	17.45%	1.57	2,384,200	-36.80%
FBRX	FORTE BIOSCIENCES INC	$7.34	1.10%	24.62%	32.97%	-52.95%	63.11%	-60.32%	-78.72%	-98.47%	N/A	$28.68	$4.11	74.41%	78.59%	0.81	17,241	-77.66%
BEAM	BEAM THERAPEUTICS INC	$17.00	2.29%	16.20%	-30.67%	-27.47%	-30.18%	-30.07%	-61.35%	6.38%	N/A	$35.25	$13.53	51.77%	25.69%	1.91	1,136,640	-34.63%
ADCT	ADC THERAPEUTICS SA	$1.21	4.31%	8.04%	-32.40%	-33.88%	-61.46%	-75.60%	-91.02%	N/A	N/A	$5.17	$1.05	76.60%	15.24%	1.19	165,808	6.52%
GLSI	GREENWICH LIFESCIENCES INC	$8.95	1.24%	-3.97%	-26.70%	-30.46%	-36.97%	-31.42%	-44.99%	N/A	N/A	$18.75	$8.06	52.27%	11.04%	0.55	71,780	29.26%
QNRX	QUOIN PHARMACEUTICALS LTD	$5.48	-8.68%	-0.20%	-10.18%	-52.04%	-58.49%	-62.63%	-99.84%	-99.98%	N/A	$31.40	$3.33	82.55%	64.63%	2.12	31,592	-60.46%
IRON	DISC MEDICINE INC	$42.17	2.84%	19.68%	-17.76%	-27.61%	-16.49%	39.25%	179.24%	N/A	N/A	$68.73	$25.64	38.65%	64.43%	0.82	347,426	-36.45%
MGX	METAGENOMI INC	$1.52	2.70%	10.14%	-19.15%	-41.76%	-23.62%	-81.58%	N/A	N/A	N/A	$8.40	$1.23	81.89%	23.58%	0.72	331,125	-28.01%
SAVA	CASSAVA SCIENCES INC	$1.44	2.86%	21.01%	-48.20%	-47.64%	-95.13%	-93.23%	-94.31%	-74.91%	-88.94%	$42.20	$1.15	96.59%	25.22%	1.36	1,191,942	63.71%
PDSB	PDS BIOTECHNOLOGY CORP	$1.08	3.85%	12.15%	-19.40%	-25.52%	-65.16%	-60.29%	-80.36%	8.54%	N/A	$4.42	$0.85	75.57%	26.91%	1.88	131,526	-13.44%
PRAX	PRAXIS PRECISION MEDICINES INC	$33.79	13.29%	18.69%	-13.20%	-52.10%	-54.90%	-33.46%	-73.31%	N/A	N/A	$91.83	$26.70	63.20%	26.55%	1.15	450,998	26.07%
TVGN	TEVOGEN BIO HOLDINGS INC	$0.98	-3.92%	-2.00%	-15.52%	-23.44%	-28.99%	-57.11%	-90.22%	N/A	N/A	$3.09	$0.26	68.28%	282.81%	0.37	537,092	5.53%
FULC	FULCRUM THERAPEUTICS INC	$3.29	7.52%	25.33%	5.45%	-16.92%	-7.32%	-53.99%	-75.19%	-70.04%	N/A	$10.13	$2.32	67.52%	42.12%	1.24	350,553	72.76%
CGON	CG ONCOLOGY INC	$20.64	2.08%	17.07%	-25.41%	-29.02%	-43.85%	-43.31%	N/A	N/A	N/A	$46.99	$14.80	56.08%	39.46%	1.55	1,109,545	-10.36%
CELU	CELULARITY INC	$1.56	-5.18%	3.67%	4.36%	-32.39%	-40.19%	-53.02%	-98.54%	-98.43%	N/A	$5.22	$1.00	70.21%	55.34%	1.05	56,804	395.67%
KROS	KEROS THERAPEUTICS INC	$14.07	3.99%	14.95%	21.08%	29.56%	-76.97%	-76.26%	-77.30%	-47.30%	N/A	$72.37	$9.12	80.56%	54.28%	1.14	1,347,177	7.34%
AVTE	AEROVATE THERAPEUTICS INC	$2.75	2.61%	6.59%	11.79%	6.59%	18.53%	-87.78%	-83.37%	N/A	N/A	$25.29	$1.25	89.12%	120.00%	1.10	178,112	62.70%
CRBU	CARIBOU BIOSCIENCES INC	$0.74	0.27%	-14.53%	-27.94%	-51.96%	-62.11%	-81.20%	-90.52%	N/A	N/A	$4.21	$0.66	82.54%	11.36%	1.78	997,951	8.98%
MBRX	MOLECULIN BIOTECH INC	$0.88	-4.79%	19.70%	-22.57%	-53.46%	-62.92%	-79.56%	-97.04%	-99.19%	N/A	$5.47	$0.40	84.00%	119.85%	0.82	272,749	-68.71%
ZBIO	ZENAS BIOPHARMA INC	$8.92	7.08%	31.56%	5.81%	13.63%	-58.43%	N/A	N/A	N/A	N/A	$26.25	$5.83	66.02%	53.00%	1.34	77,263	-3.33%
LGVN	LONGEVERON INC	$1.46	3.55%	8.15%	-15.12%	-14.12%	-33.94%	-30.14%	-98.44%	N/A	N/A	$6.40	$0.77	77.19%	89.36%	1.23	86,658	44.15%
THRD	THIRD HARMONIC BIO INC	$5.16	0.58%	48.70%	48.28%	-10.88%	-60.64%	-54.26%	N/A	N/A	N/A	$16.94	$3.18	69.54%	62.26%	0.80	526,107	-16.93%
ORKA	ORUKA THERAPEUTICS INC	$9.22	7.08%	25.10%	-22.46%	-24.73%	-68.00%	-76.06%	-66.88%	-83.26%	-99.29%	$53.88	$5.49	82.89%	68.09%	0.55	150,023	-19.59%
KRRO	KORRO BIO INC	$13.90	3.27%	7.17%	-44.53%	-62.43%	-82.63%	-79.94%	-85.45%	-98.26%	N/A	$98.00	$11.13	85.82%	24.89%	1.07	84,630	-28.14%
ALLO	ALLOGENE THERAPEUTICS INC	$1.45	3.57%	5.84%	-21.62%	-20.33%	-46.10%	-58.69%	-81.39%	-94.75%	N/A	$3.78	$1.23	61.64%	17.89%	1.38	2,056,913	61.53%
HLVX	HILLEVAX INC	$1.69	2.42%	9.03%	-4.52%	-11.05%	-9.63%	-86.51%	N/A	N/A	N/A	$16.31	$1.34	89.64%	26.12%	1.08	115,106	-61.23%
CLYM	CLIMB BIO INC	$1.26	0.00%	8.62%	-10.00%	-35.38%	-74.07%	-71.56%	-84.82%	N/A	N/A	$11.55	$1.05	89.09%	20.00%	0.67	80,078	-19.37%
BLTE	BELITE BIO INC	$56.40	-1.54%	-3.62%	-16.83%	0.34%	0.71%	74.45%	N/A	N/A	N/A	$86.53	$32.50	34.82%	73.54%	0.14	20,440	80.63%
ABSI	ABSCI CORP	$3.09	1.31%	25.87%	-3.74%	6.55%	-23.13%	-41.59%	-58.47%	N/A	N/A	$6.33	$2.01	51.18%	53.73%	2.14	1,634,531	-33.09%
ATOS	ATOSSA THERAPEUTICS INC	$0.62	2.98%	5.59%	-14.66%	-24.58%	-57.03%	-53.85%	-43.87%	-69.90%	-99.79%	$1.81	$0.55	65.58%	12.66%	1.30	416,174	-30.99%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$15.71	-0.95%	-9.19%	-3.50%	-33.29%	-12.43%	-96.92%	-99.99%	-100.00%	-100.00%	$672.00	$6.76	97.66%	132.40%	1.00	312,582	-45.78%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$6.84	1.18%	1.18%	-21.11%	-45.45%	-54.64%	-53.94%	-38.54%	N/A	N/A	$18.07	$6.41	62.15%	6.71%	0.75	1,189,201	13.82%
ROIV	ROIVANT SCIENCES LTD	$10.15	1.30%	5.18%	-6.45%	-8.97%	-14.78%	-2.78%	165.01%	N/A	N/A	$13.06	$8.73	22.25%	16.27%	0.84	2,625,469	-44.22%
SCPH	SCPHARMACEUTICALS INC	$2.57	0.78%	27.54%	-14.33%	-21.65%	-41.46%	-41.86%	-48.91%	-71.38%	N/A	$5.65	$1.94	54.51%	32.47%	0.94	249,629	-0.63%
CGEN	COMPUGEN LTD	$1.47	1.38%	21.49%	-9.82%	-34.67%	-15.03%	-22.63%	-42.80%	-88.65%	-79.38%	$2.66	$1.13	44.74%	30.09%	1.71	240,620	-30.11%
NKTX	NKARTA INC	$1.81	3.43%	18.30%	11.73%	-26.72%	-54.75%	-76.97%	-78.22%	N/A	N/A	$8.33	$1.31	78.27%	38.17%	1.44	523,949	-60.47%
DRMA	DERMATA THERAPEUTICS INC	$0.73	2.68%	-7.49%	-37.69%	-45.19%	-53.86%	-83.52%	-99.74%	N/A	N/A	$6.17	$0.70	88.19%	4.14%	0.50	44,851	-61.16%
CMPX	COMPASS THERAPEUTICS INC	$1.75	2.94%	6.06%	-25.53%	-32.69%	-8.14%	14.38%	15.89%	N/A	N/A	$4.08	$0.77	57.11%	128.76%	0.94	692,971	23.33%
IDYA	IDEAYA BIOSCIENCES INC	$17.08	5.56%	8.31%	-10.72%	-22.99%	-44.35%	-57.48%	63.29%	279.56%	N/A	$44.42	$13.45	61.55%	26.99%	1.14	1,658,210	36.15%
GHRS	GH RESEARCH PLC	$9.10	4.60%	5.08%	-14.55%	2.48%	13.75%	-17.20%	-52.31%	N/A	N/A	$20.50	$6.00	55.61%	51.67%	0.95	190,763	43.90%
URGN	UROGEN PHARMA LTD	$9.67	-6.93%	2.98%	-15.55%	-5.84%	-24.69%	-32.09%	33.01%	-59.32%	N/A	$20.70	$8.94	53.29%	8.17%	0.84	741,549	170.45%
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$10.00	7.82%	6.38%	17.65%	7.87%	151.26%	35.17%	-95.04%	N/A	N/A	$13.70	$2.31	27.01%	332.90%	0.36	68,393	175.20%
MTSR	METSERA INC	$19.57	11.51%	49.62%	-31.04%	N/A	N/A	N/A	N/A	N/A	N/A	$32.81	$12.30	40.35%	59.11%	1.60	1,304,388	22.10%
OCS	OCULIS HOLDING AG	$18.27	1.39%	13.13%	-2.97%	-19.66%	28.93%	53.53%	86.81%	N/A	N/A	$23.08	$10.79	20.84%	69.32%	0.26	25,926	-10.36%
DMAC	DIAMEDICA THERAPEUTICS INC	$3.54	2.02%	0.85%	-40.90%	-38.00%	-17.48%	36.15%	63.13%	2.46%	N/A	$6.82	$2.14	48.08%	65.42%	0.77	46,109	-45.32%
LQDA	LIQUIDIA CORP	$13.72	0.29%	10.73%	-7.23%	6.44%	19.72%	-1.01%	166.93%	87.95%	N/A	$16.81	$8.26	18.38%	66.10%	0.97	597,970	-15.07%
TERN	TERNS PHARMACEUTICALS INC	$2.40	7.14%	12.15%	-26.15%	-45.82%	-68.00%	-47.14%	4.58%	N/A	N/A	$11.40	$1.87	78.95%	28.69%	0.96	891,657	-9.08%
TELO	TELOMIR PHARMACEUTICALS INC	$2.48	-0.40%	-6.42%	-40.53%	-47.12%	-48.55%	-70.75%	N/A	N/A	N/A	$8.40	$2.38	70.48%	4.20%	1.02	56,080	-40.87%
ACOG	ALPHA COGNITION INC	$4.12	-3.06%	-1.20%	-27.59%	-30.87%	N/A	N/A	N/A	N/A	N/A	$7.00	$3.75	41.14%	9.87%	0.78	64,822	16.65%
SLN	SILENCE THERAPEUTICS PLC	$3.14	8.28%	43.38%	-19.49%	-38.67%	-83.03%	-85.44%	-81.10%	N/A	N/A	$24.38	$1.97	87.12%	59.39%	0.61	296,460	5.58%
IGMS	IGM BIOSCIENCES INC	$1.22	2.52%	15.09%	-0.81%	-31.07%	-92.39%	-84.99%	-93.52%	-97.97%	N/A	$22.50	$0.92	94.58%	32.61%	1.57	90,455	-25.45%
ITOS	ITEOS THERAPEUTICS INC	$6.51	4.66%	25.68%	-11.55%	-18.63%	-32.26%	-39.04%	-79.38%	N/A	N/A	$18.75	$4.80	65.28%	35.63%	1.05	1,010,380	35.52%
IRD	OPUS GENETICS INC	$0.76	3.40%	6.44%	-19.32%	-32.74%	-40.16%	-56.32%	-71.32%	-90.00%	-99.79%	$2.18	$0.65	65.14%	16.92%	0.80	52,772	-70.02%
VYNE	VYNE THERAPEUTICS INC	$1.85	2.49%	25.00%	-1.07%	-31.48%	-15.53%	-22.92%	-79.07%	-98.02%	N/A	$4.30	$1.44	56.98%	28.47%	1.15	79,300	-31.09%
PRQR	PROQR THERAPEUTICS NV	$1.14	0.00%	0.88%	-32.94%	-51.90%	-74.61%	-40.00%	52.82%	-77.51%	-94.29%	$4.62	$1.07	75.32%	6.54%	0.97	464,865	40.20%
ATNM	ACTINIUM PHARMACEUTICALS INC	$1.21	-3.20%	5.22%	-6.92%	-13.57%	-29.65%	-83.31%	-81.72%	-81.25%	-98.81%	$10.24	$1.03	88.18%	17.59%	1.07	323,482	72.03%
NUVB	NUVATION BIO INC	$1.97	4.79%	12.57%	-5.74%	-21.51%	-18.93%	-26.77%	-63.25%	N/A	N/A	$3.97	$1.54	50.38%	27.92%	1.14	2,956,314	-13.81%
PEPG	PEPGEN INC	$1.33	8.13%	13.68%	-43.40%	-42.17%	-85.01%	-88.43%	N/A	N/A	N/A	$19.30	$0.88	93.11%	51.14%	1.30	192,196	49.57%
OLMA	OLEMA PHARMACEUTICALS INC	$4.42	3.76%	29.62%	-0.67%	-21.91%	-64.09%	-58.73%	50.85%	N/A	N/A	$16.62	$2.86	73.41%	54.55%	1.35	615,574	-20.24%
GRI	GRI BIO INC	$1.51	-1.31%	24.79%	-73.13%	-87.67%	-81.84%	-98.66%	-100.00%	N/A	N/A	$117.11	$1.10	98.71%	37.27%	0.79	154,513	-5.89%
CING	CINGULATE INC	$4.24	1.44%	15.85%	14.59%	-10.92%	-5.57%	-58.52%	-98.93%	N/A	N/A	$20.83	$1.80	79.64%	135.56%	0.98	61,148	-21.54%
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$0.78	10.30%	34.83%	-28.91%	-55.82%	-38.91%	-75.56%	-62.40%	-92.59%	N/A	$4.28	$0.49	81.73%	61.24%	0.57	323,022	15.25%
ANRO	ALTO NEUROSCIENCE INC	$2.26	0.44%	10.24%	-26.86%	-51.29%	-84.16%	-83.23%	N/A	N/A	N/A	$17.55	$1.60	87.12%	41.25%	0.78	148,826	-39.73%
JANX	JANUX THERAPEUTICS INC	$29.69	3.49%	10.49%	-5.78%	-27.09%	-40.39%	-38.09%	120.09%	N/A	N/A	$71.71	$22.52	58.60%	31.84%	1.53	367,175	-12.58%
XENE	XENON PHARMACEUTICALS INC	$35.11	3.94%	14.25%	-1.38%	-8.85%	-18.93%	-15.66%	7.67%	178.43%	121.51%	$46.00	$26.74	23.67%	31.30%	0.79	825,775	18.82%
DRTS	ALPHA TAU MEDICAL LTD	$2.57	1.58%	2.80%	-3.38%	-34.27%	11.74%	-4.46%	-74.80%	N/A	N/A	$4.39	$1.75	41.42%	46.86%	0.38	4,025	-65.28%
ADTX	ADITXT INC	$2.50	13.64%	-13.19%	-42.79%	-92.40%	-99.07%	-99.99%	-100.00%	N/A	N/A	$27.20k	$2.04	99.99%	22.55%	0.53	719,805	143.55%
MBIO	MUSTANG BIO INC	$1.33	-0.75%	-0.75%	-6.34%	-76.04%	-87.75%	-93.07%	-99.78%	-99.94%	N/A	$65.00	$1.15	97.95%	15.65%	1.64	32,974	262.55%
VSTM	VERASTEM INC	$5.74	15.73%	26.99%	-20.61%	7.69%	115.79%	-47.05%	-73.86%	-84.96%	-95.10%	$13.52	$2.10	57.54%	173.33%	1.52	1,159,267	147.50%
CNTA	CENTESSA PHARMACEUTICALS PLC	$12.30	3.93%	9.09%	-28.52%	-18.90%	-22.23%	14.05%	41.32%	N/A	N/A	$19.09	$7.75	35.59%	58.65%	1.00	784,645	-0.39%
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$6.03	1.86%	5.98%	-13.36%	-49.41%	-67.63%	-83.77%	-44.70%	-96.62%	-93.66%	$61.90	$4.64	90.26%	29.96%	1.51	121,749	-11.85%
GANX	GAIN THERAPEUTICS INC	$1.80	3.45%	13.92%	-25.00%	-21.05%	-35.02%	-43.40%	-53.00%	N/A	N/A	$3.65	$0.89	50.68%	102.25%	1.06	149,571	-15.45%
APVO	APTEVO THERAPEUTICS INC	$0.86	-3.47%	-12.13%	-67.35%	-80.67%	-85.49%	-96.73%	-99.99%	-99.99%	N/A	$51.06	$0.83	98.31%	3.86%	1.25	173,554	-33.60%
STRO	SUTRO BIOPHARMA INC	$0.53	-2.78%	-8.22%	-43.67%	-73.88%	-85.85%	-86.18%	-92.29%	-94.80%	N/A	$5.17	$0.52	89.85%	0.38%	1.27	1,337,203	11.57%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$1.97	-0.51%	9.44%	-38.63%	-13.22%	-52.47%	-60.56%	-91.24%	-87.69%	N/A	$6.90	$1.69	71.45%	16.57%	0.32	78,518	94.05%
NNVC	NANOVIRICIDES INC	$1.33	-5.00%	24.30%	1.53%	11.76%	-10.74%	14.66%	-29.63%	-75.09%	-96.85%	$3.59	$0.94	62.95%	41.49%	0.78	106,881	-67.15%
VRAX	VIRAX BIOLABS GROUP LTD	$0.99	-3.50%	13.47%	-22.34%	-54.40%	-36.28%	44.48%	N/A	N/A	N/A	$9.00	$0.60	88.96%	65.67%	0.62	185,351	406.69%
SRRK	SCHOLAR ROCK HOLDING CORP	$30.75	3.33%	16.88%	-11.43%	-28.70%	5.13%	124.45%	205.06%	97.75%	N/A	$46.98	$6.76	34.55%	354.88%	0.80	923,615	-41.44%
REVB	REVELATION BIOSCIENCES INC	$3.08	2.67%	2.33%	2.67%	-51.89%	-77.35%	-91.05%	-99.98%	N/A	N/A	$60.80	$2.36	94.93%	30.51%	1.03	11,086	-90.47%
BCTX	BRIACELL THERAPEUTICS CORP	$4.29	-4.24%	6.98%	5.41%	-24.34%	-66.15%	-86.76%	-96.26%	N/A	N/A	$36.60	$3.00	88.28%	43.00%	0.94	502,873	-97.47%
VTGN	VISTAGEN THERAPEUTICS INC	$2.11	1.93%	2.93%	-25.04%	-27.74%	-31.05%	-54.82%	-95.34%	-82.61%	N/A	$5.00	$1.90	57.80%	11.05%	1.63	70,760	-60.33%
AGIO	AGIOS PHARMACEUTICALS INC	$27.66	1.92%	9.28%	-13.54%	-14.68%	-37.34%	-4.72%	8.17%	-39.06%	-74.32%	$62.58	$23.42	55.80%	18.13%	1.19	590,694	7.66%
PHAT	PHATHOM PHARMACEUTICALS INC	$4.03	-4.62%	-1.95%	-16.74%	-42.10%	-75.18%	-58.88%	-72.26%	-86.78%	N/A	$19.71	$3.81	79.55%	5.77%	1.42	956,154	-25.24%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 664 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 126.96% over the past year, overperforming other biotech stocks by 206 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 474.71% from Protalix Biotherapeutics's current stock price of $2.61.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 664 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 57.84% over the past year, overperforming other biotech stocks by 136 percentage points.

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #3 top biotech stock out of 664 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: D, Financials: B, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 52, which is 28 points higher than the biotech industry average of 24.

RIGL passed 17 out of 33 due diligence checks and has strong fundamentals. Rigel Pharmaceuticals has seen its stock return 51.8% over the past year, overperforming other biotech stocks by 130 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $36.80, an upside of 118.4% from Rigel Pharmaceuticals's current stock price of $16.85.

Rigel Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Rigel Pharmaceuticals, 20% have issued a Strong Buy rating, 20% have issued a Buy, 60% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 8.02%, which is 6 percentage points higher than the biotech industry average of 2.16%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.78%, which is 1 percentage points higher than the biotech industry average of 2.16%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.32%, which is -1 percentage points lower than the biotech industry average of 2.16%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.44% in the last day, and up 7.32% over the last week. Channel Therapeutics was the among the top gainers in the biotechnology industry, gaining 46.61% yesterday.

Channel Therapeutics shares are trading higher after the company announced that it will combine with Ligand Subsidiary Pelthos Therapeutics to create a pain medicines focused entity.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -44.68% in the past year. It has overperformed other stocks in the biotech industry by 34 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -2.5% in the past year. It has overperformed other stocks in the biotech industry by 76 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has dropped -4.03% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

55.56% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 119.43% over the next year.

1.96% of biotech stocks have a Zen Rating of A (Strong Buy), 4.36% of biotech stocks are rated B (Buy), 40.74% are rated C (Hold), 36.38% are rated D (Sell), and 16.56% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -177.72x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.